Acute pancreatitis in patients with severe fever with thrombocytopenia syndrome virus infection

被引:14
|
作者
Tian, Bing [1 ,4 ]
Qu, Da [2 ]
Sasaki, Akihito [3 ]
Chen, Jingyi [5 ]
Deng, Baocheng [1 ]
机构
[1] China Med Univ, Affiliated Hosp 1, Infect Dis Dept, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Affiliated Hosp 1, Radiol Dept, Shenyang 110001, Peoples R China
[3] Shinseikai Toyama Hosp, Dept Internal Med, 89-10 Shimowaka, Imizu, Toyama 9390243, Japan
[4] Southeast Univ, Infect Dis Dept, Zhongda Hosp, Nanjing 210009, Peoples R China
[5] Nankai Univ, Clin Coll Ophthalmol, Sch Med, Tianjin 300071, Tianjin Provinc, Peoples R China
关键词
Acute pancreatitis; Severe fever with thrombocytopenia syndrome; Severe fever with thrombocytopenia syndrome virus;
D O I
10.1016/j.pan.2020.09.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Severe fever with thrombocytopenia syndrome (SETS), a novel tick-borne disease caused by SFTS virus (SFTSV), has been reported in China, Japan, South Korea, and Vietnam since 2009. SFTSV infection can cause multiple organ damage, including acute pancreatitis (AP). We summarize the clinical features, treatment and outcome of AP associated with SFTSV. Methods: We retrospectively review the clinical manifestations, laboratory tests, treatment, and outcome of AP associated with SFTSV infection from January 2009 to December 2018 in Liaoning Province, China. Results: A total of 418 SFTS patients were reviewed. Fifteen (3.6%) of 418 met the criteria for AP associated with SFTSV infection. The first reported symptom for all SFTS-AP patients was fever. All the SFTS-AP patients presented with thrombocytopenia, and 13 (86.7%) of them presented with leukopenia on admission. Thirteen (86.7%) of 15 SFTS-AP patients were severe SFTS patients, and 9 (60.0%) patients were diagnosed with multiple organ dysfunction syndrome. One SFTS-AP patient died of multiple organ failure. Six (40%) of 15 SFTS-AP patients were not confirmed with SFTSV infection when AP was diagnosed, and the median delay between SFTSV infection and AP diagnosis was 5 days (range, 2-7 days). Conclusions: AP is not a frequent complication of SFTS, and is more frequently seen in severe SFTS patients. Most patients with SFTS-AP have mild or moderate disease, and can recover with conservative management; however, severe SFTS-AP can be fatal. In SFTS endemic areas, clinicians should be alert to the possibility of SFTS when AP patients with tick exposure, thrombocytopenia, and leukopenia have a fever before abdominal pain. (C) 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1631 / 1636
页数:6
相关论文
共 50 条
  • [21] Infection Route Impacts the Pathogenesis of Severe Fever with Thrombocytopenia Syndrome Virus in Ferrets
    Park, Su-Jin
    Kim, Young-Il
    Casel, Mark Anthony
    Kim, Eun-Ha
    Kim, Se-Mi
    Yu, Kwang-Min
    Rollon, Rare
    Jang, Seung-Gyu
    Jeong, Hye Won
    Choi, Young Ki
    VIRUSES-BASEL, 2022, 14 (06):
  • [22] Hsp90 β is critical for the infection of severe fever with thrombocytopenia syndrome virus
    Wang, Bo
    Zhang, Leike
    Deng, Fei
    Hu, Zhihong
    Wang, Manli
    Liu, Jia
    VIROLOGICA SINICA, 2024, 39 (01) : 113 - 122
  • [23] Human Case of Severe Fever with Thrombocytopenia Syndrome Virus Infection, Taiwan, 2019
    Peng, Shih-Huan
    Yang, Su-Lin
    Tang, Shih-En
    Wang, Tzy-Chen
    Hsu, Tung-Chien
    Su, Chien-Ling
    Chen, Meng-Yu
    Shimojima, Masayuki
    Yoshikawa, Tomoki
    Shu, Pei-Yun
    EMERGING INFECTIOUS DISEASES, 2020, 26 (07) : 1612 - 1614
  • [24] Acute Myocarditis with Severe Fever and Thrombocytopenia Syndrome
    Okutsu, Shota
    Futami, Makito
    Arimura, Tadaaki
    Ohki, Kosuke
    Hiyoshi, Tetsuya
    Sakihara, Eishi
    Kato, Yoshifumi
    Ueda, Yoko
    Yano, Masaya
    Takeshita, Morishige
    Ishikura, Hiroyasu
    Suzuki, Tadaki
    Kato, Seiya
    Miura, Shin-ichiro
    Nabeshima, Shigeki
    INTERNAL MEDICINE, 2022, 61 (11) : 1779 - 1784
  • [25] Changes in Cytokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus
    Xu, Da-Li
    Zhang, Xiao-Mei
    Tian, Xue-Ying
    Wang, Xian-Jun
    Zhao, Lin
    Gao, Meng-Ying
    Li, Lian-Feng
    Zhao, Jia-Qi
    Cao, Wu-Chun
    Ding, Shu-Jun
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 211 - 222
  • [26] Cytokine and Chemokine Levels in Patients with Severe Fever with Thrombocytopenia Syndrome Virus
    Deng, Baocheng
    Zhang, Shujun
    Geng, Yingzhi
    Zhang, Yuzhong
    Wang, Yuncheng
    Yao, Wenqing
    Wen, Ying
    Cui, Wei
    Zhou, Ying
    Gu, Qiuhong
    Wang, Wen
    Wang, Yu
    Shao, Zhen
    Wang, Yanli
    Li, Chengbo
    Wang, Donglei
    Zhao, Yitong
    Liu, Pei
    PLOS ONE, 2012, 7 (07):
  • [27] DRUG REPURPOSING FOR SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS
    Chan, Jasper
    Yuan, Shuofeng
    Wen, Lei
    Ye, Zi-Wei
    Jin, Dong-Yan
    Yuen, Kwok-Yung
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 468 - 469
  • [28] Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice
    Westover, Jonna B.
    Hickerson, Brady T.
    Van Wettere, Arnaud J.
    Hurst, Brett L.
    Kurz, Jacqueline P.
    Dagley, Ashley
    Wuelfroth, Petra
    Komeno, Takashi
    Furuta, Yousuke
    Steiner, Thomas
    Gowen, Brian B.
    PATHOGENS, 2019, 8 (04):
  • [29] Quantitative assessment on the epidemic characteristics of severe fever with thrombocytopenia syndrome virus infection in China
    Jiang, Shengyao
    Shah, Mian Khaqan
    Cui, Li
    BIOSAFETY AND HEALTH, 2021, 3 (05) : 292 - 299
  • [30] Seroprevalence and risk factors of severe fever with thrombocytopenia syndrome virus infection in endemic areas
    Lyu, Yong
    Ding, Fan
    Sun, Jie
    Xu, Peng-Peng
    Hu, Jie-Ying
    Xie, Shao-Yu
    Li, Kai-Chun
    Chang, Hong-Wei
    Qin, Wei
    Yu, Liang
    Xie, Hua
    Li, Guang-Jiang
    Yang, Cheng-Wu
    Huang, Xiao-Xia
    Wang, Qin
    Zhang, Xiu-Jun
    INFECTIOUS DISEASES, 2016, 48 (07) : 544 - 549